These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35213654)

  • 21. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
    Jung SE; Joo NS; Han KS; Kim KN
    J Korean Med Sci; 2017 Jun; 32(6):948-953. PubMed ID: 28480652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
    Furnari M; De Alessandri A; Cresta F; Haupt M; Bassi M; Calvi A; Haupt R; Bodini G; Ahmed I; Bagnasco F; Giannini EG; Casciaro R
    J Gastroenterol; 2019 Mar; 54(3):261-270. PubMed ID: 30232597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis.
    Feng X; Li X; Zhang X; Chen W; Tian Y; Yang Q; Yang Y; Pan H; Jiang Z
    Biomed Res Int; 2022; 2022():2469513. PubMed ID: 36303585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients.
    Jun DW; Kim KT; Lee OY; Chae JD; Son BK; Kim SH; Jo YJ; Park YS
    Dig Dis Sci; 2010 May; 55(5):1465-71. PubMed ID: 19517230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.
    Petrone P; Sarkisyan G; Fernández M; Coloma E; Akopian G; Ortega A; Kaufman HS
    Arch Surg; 2011 Apr; 146(4):444-7. PubMed ID: 21502453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy.
    Lunia MK; Sharma BC; Sachdeva S
    Hepatol Int; 2013 Mar; 7(1):268-73. PubMed ID: 26201641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care.
    DE Bastiani R; Lopetuso LR; DE Bastiani M; Bacchin P; Benedetto E; Boscariolo L; Caneve R; Chesani F; Chiumeo F; Civic Z; Dainese A; DE Polo M; Disclafani G; Grattagliano I; Mana O; Mancuso M; Mastronuzzi T; Pati A; Pirrotta E; Salandini M; Sanna G; Scoglio R; Severino P; Tosetti C; Turnava L; Zamparella M; Elisei W; Gasbarrini A; Tursi A
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):523-528. PubMed ID: 36943203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.
    Lakshmi CP; Ghoshal UC; Kumar S; Goel A; Misra A; Mohindra S; Choudhuri G
    Dig Dis Sci; 2010 Apr; 55(4):1142-8. PubMed ID: 19424796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
    Reddymasu SC; Sostarich S; McCallum RW
    BMC Gastroenterol; 2010 Feb; 10():23. PubMed ID: 20175924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can concurrent lower gastrointestinal manifestations help the timely diagnosis of small intestinal bacterial overgrowth in CVID patients?
    Baniadam L; Arshi S; Nabavi M; Yousefi A; Fallahpour M; Shokri S; Zare Mehrjerdi F; Salari F; Bemanian MH
    Eur Ann Allergy Clin Immunol; 2021 Jan; 53(1):18-22. PubMed ID: 32186350
    [No Abstract]   [Full Text] [Related]  

  • 32. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.
    Ghosh G; Jesudian AB
    J Clin Exp Hepatol; 2019; 9(2):257-267. PubMed ID: 31024208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy.
    Schulz C; Schütte K; Vilchez-Vargas R; Vasapolli R; Malfertheiner P
    Dig Dis; 2019; 37(2):161-169. PubMed ID: 30428474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional
    Enko D; Kriegshäuser G
    Clin Biochem; 2017 Jan; 50(1-2):46-49. PubMed ID: 27586816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
    Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
    Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Behçet's disease.
    Jo JH; Park SJ; Cheon JH; Kim TI; Kim WH
    J Gastroenterol Hepatol; 2018 Feb; 33(2):375-379. PubMed ID: 28666309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome.
    Ding XW; Liu YX; Fang XC; Liu K; Wei YY; Shan MH
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5191-5196. PubMed ID: 29228433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time.
    Ghoshal UC; Ghoshal U; Das K; Misra A
    Indian J Gastroenterol; 2006; 25(1):6-10. PubMed ID: 16567886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.